Hunter Land

Company: Biopharmaceutical Research Co.

Job title: Vice President, Research & Development

Seminars:

Developing a Framework for Scaling Preclinical Findings to Clinical Success in Cannabinoid Drug Development 11:00 am

Navigating regulatory pathways for cannabinoid medicines – insights from the development of Epidiolex and Sativex, including botanical drug guidance, fixed dose concentration, and the FDA 505(b)(2) pathway Streamlining approval and compliance for minor cannabinoids – strategies for aligning with regulatory guidelines to ensure safety and efficacy, focusing on cannabinoid combination studies (entourage vs non-tourage) Discussing…Read more

day: Day Two

Roundtable Discussion: Evolving Preclinical & Clinical Trial Design for Cannabinoid Drug Development 11:30 am

Why have there been relatively few approvals to date of cannabinoid and CB1 and CB2 targeting drugs? What promising potential of cannabinoids is there beyond their approved use in conditions like multiple sclerosis, neuropathic pain, and obesity? How can we choose the right active ingredient, taking into account safety, efficacy, and therapeutic benefits? How can…Read more

day: Day Two